Amicus Therapeutics Announces Participation at the 2022 AANEM Annual Meeting
PHILADELPHIA, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced three poster presentations highlighting its development program for Pompe disease will be included at the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, being held September 21-24, 2022 in Nashville, TN and virtually.
The posters will be made available on the Amicus website following their respective presentations at the conference.
For more information on the 2022 AANEM Annual Meeting, please visit www.aanem.org.
About Amicus Therapeutics